HIHI launches new clinicial evaluation study with Project Sirius an innovative technology which is set to significantly advance cancer screeing
Realising the value and future of AI in healthcare diagnostics and screening Health Innovation Hub Ireland has launched an AI based Clinical Evaluation study with Project Sirius. The team, based at Dublin City University has developed an innovative technology with the potential to significantly advance cancer screening.
The project, which has received Enterprise Ireland commercialisation funding is led by Professor Tia Keyes, along with Co-PIs, Dr Damien King and Professor Mark Roantree, represents an interdisciplinary collaboration across Dublin City University.
Cancer occurs where cells in a specific part of the body grow and reproduce uncontrollably and lead to damage in surrounding healthy tissue. It is estimated that one in two people will develop some form of cancer in their lifetime. The ability for early identification of specific types of cancer from one blood test would be hugely beneficial to patients and the healthcare system.
Project Sirius is now developing a simple to use, one step, low-cost and scalable diagnostic platform. It aims to identify and classify specific extracellular vesicles called Exosomes by using a highly sensitive minimally invasive liquid biopsy (i.e blood sample) test and AI analysis of Surface Enhanced Raman Spectroscopy data to identify exosomes which are specific to each breast cancer subtype. The project is initially focussed on Breast Cancer but has applications across many different cancer types and may be particularly valuable for cancers that are not easily detected using current technology (e.g. dense breast tissue).
HIHI’s clinical evaluation study facilitated five separate evaluation sessions with seven clinical experts including key personnel in the National Cancer Screening Programme and several consultant medical oncologists.
Peter Kidney Commercial Lead, of Project Sirius highlighted the value of HIHI to the project: “Through their network, we were able to engage directly with expert clinicians who provided invaluable feedback on our innovation. Their insights not only validated key aspects of our solution but also highlighted practical considerations for further development. The access to clinical expertise through HIHI helped us refine our product in a real-world context. We’re incredibly grateful for the opportunity and would highly recommend HIHI to any innovator looking to make a real impact in healthcare.”
Read the full case study here https://hih.ie/downloads/case-studies/HIHI-case-study_Project-Sirius.pdf
HIHI is also currently running an AI in healthcare competition.
Submit your innovation by following this link. https://hih.ie/initiatives/hihi-ai/
